|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Hohenberger P and Gretschel S: Gastric
cancer. Lancet. 362:305–315. 2003. View Article : Google Scholar
|
|
3
|
El-Omar EM, Carrington M, Chow WH, et al:
Interleukin-1 polymorphisms associated with increased risk of
gastric cancer. Nature. 404:398–402. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Omar EM, Rabkin CS, Gammon MD, et al:
Increased risk of noncardia gastric cancer associated with
proinflammatory cytokine gene polymorphisms. Gastroenterology.
124:1193–1201. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugimoto M, Furuta T, Shirai N, et al:
Poor metabolizer genotype status of CYP2C19 is a risk factor for
developing gastric cancer in Japanese patients with Helicobacter
pylori infection. Aliment Pharmacol Ther. 22:1033–1040. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu H, Hsu PI, Graham DY and Yamaoka Y:
Duodenal ulcer promoting gene of Helicobacter pylori.
Gastroenterology. 128:833–848. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamaoka Y, Ojo O, Fujimoto S, et al:
Helicobacter pylori outer membrane proteins and
gastroduodenal disease. Gut. 55:775–781. 2006. View Article : Google Scholar
|
|
8
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
9
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li P, Chen X, Su L, et al: Epigenetic
silencing of miR-338-3p contributes to tumorigenicity in gastric
cancer by targeting SSX2IP. PLoS One. 8:e667822013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou J, Teng R, Xu C, et al:
Overexpression of ERα inhibits proliferation and invasion of MKN28
gastric cancer cells by suppressing β-catenin. Oncol Rep.
30:1622–1630. 2013.
|
|
12
|
Tian C, Zhang L, Hu D and Ji J: Ghrelin
induces gastric cancer cell proliferation, migration, and invasion
through GHS-R/NF-κB signaling pathway. Mol Cell Biochem.
382:163–172. 2013.PubMed/NCBI
|
|
13
|
Lesogor A, Cohn JN, Latini R, et al:
Interaction between baseline and early worsening of renal function
and efficacy of renin-angiotensin-aldosterone system blockade in
patients with heart failure: insights from the Val-HeFT study. Eur
J Heart Fail. 15:1236–1244. 2013. View Article : Google Scholar
|
|
14
|
Li P, Sun HJ, Cui BP, Zhou YB and Han Y:
Angiotensin-(1–7) in the rostral ventrolateral medulla modulates
enhanced cardiac sympathetic afferent reflex and sympathetic
activation in renovascular hypertensive rats. Hypertension.
61:820–827. 2013.
|
|
15
|
Suzuki Y, Ruiz-Ortega M, Lorenzo O,
Ruperez M, Esteban V and Egido J: Inflammation and angiotensin II.
Int J Biochem Cell Biol. 35:881–900. 2003. View Article : Google Scholar
|
|
16
|
Le Noble FA, Hekking JW, Van Straaten HW,
Slaaf DW and Struyker Boudier HA: Angiotensin II stimulates
angiogenesis in the chorio-allantoic membrane of the chick embryo.
Eur J Pharmacol. 195:305–306. 1991.PubMed/NCBI
|
|
17
|
Muramatsu M, Yamada M, Takai S and
Miyazaki M: Suppression of basic fibroblast growth factor-induced
angiogenesis by a specific chymase inhibitor, BCEAB, through the
chymase-angiotensin-dependent pathway in hamster sponge granulomas.
Br J Pharmacol. 137:554–560. 2002. View Article : Google Scholar
|
|
18
|
Carl-McGrath S, Ebert MP, Lendeckel U and
Röcken C: Expression of the local angiotensin II system in gastric
cancer may facilitate lymphatic invasion and nodal spread. Cancer
Biol Ther. 6:1218–1226. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sugimoto M, Ohno T and Yamaoka Y:
Expression of angiotensin II type 1 and type 2 receptor mRNAs in
the gastric mucosa of Helicobacter pylori-infected Mongolian
gerbils. J Gastroenterol. 46:1177–1186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kinoshita J, Fushida S, Harada S, et al:
Local angiotensin II-generation in human gastric cancer:
Correlation with tumor progression through the activation of
ERK1/2, NF-κB and survivin. Int J Oncol. 34:1573–1582.
2009.PubMed/NCBI
|
|
21
|
Ishikawa M, Kitayama J, Yamauchi T, et al:
Adiponectin inhibits the growth and peritoneal metastasis of
gastric cancer through its specific membrane receptors AdipoR1 and
AdipoR2. Cancer Sci. 98:1120–1127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Savry A, Carre M, Berges R, et al:
Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy
through Bim overexpression: implications for cancer treatment.
Neoplasia. 15:49–60. 2013.PubMed/NCBI
|
|
23
|
Wang L, Cai SR, Zhang CH, et al: Effects
of angiotensin-converting enzyme inhibitors and angiotensin II type
1 receptor blockers on lymphangiogenesis of gastric cancer in a
nude mouse model. Chin Med J (Engl). 121:2167–2171. 2008.PubMed/NCBI
|
|
24
|
Huang W, Wu YL, Zhong J, Jiang FX, Tian XL
and Yu LF: Angiotensin II type 1 receptor antagonist suppress
angiogenesis and growth of gastric cancer xenografts. Dig Dis Sci.
53:1206–1210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sugimoto M, Yamaoka Y, Shirai N and Furuta
T: Role of renin-angiotensin system in gastric oncogenesis. J
Gastroenterol Hepatol. 27:442–451. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ebert MP, Lendeckel U, Westphal S, et al:
The angiotensin I-converting enzyme gene insertion/deletion
polymorphism is linked to early gastric cancer. Cancer Epidemiol
Biomarkers Prev. 14:2987–2989. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Röcken C, Lendeckel U, Dierkes J, et al:
The number of lymph node metastases in gastric cancer correlates
with the angiotensin I-converting enzyme gene insertion/deletion
polymorphism. Clin Cancer Res. 11:2526–2530. 2005.PubMed/NCBI
|
|
28
|
Huang W, Yu LF, Zhong J, et al: Stat3 is
involved in angiotensin II-induced expression of MMP2 in gastric
cancer cells. Dig Dis Sci. 54:2056–2062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tong JJ, Yan Z, Jian R, Tao H, Hui OT and
Jian C: RhoA regulates invasion of glioma cells via the c-Jun
NH2-terminal kinase pathway under hypoxia. Oncol Lett.
4:495–500. 2012.PubMed/NCBI
|
|
30
|
Murray NP, Reyes E, Badinez L, et al:
Effect of androgen blockade on HER-2 and matrix metalloproteinase-2
expression on bone marrow micrometastasis and stromal cells in men
with prostate cancer. Scientific World Journal. 2013:2812912013.
View Article : Google Scholar
|
|
31
|
Huang T, Chen MH, Wu MY and Wu XY:
Correlation between expression of extracellular matrix
metalloproteinase inducer and matrix metalloproteinase-2 and
cervical lymph node metastasis of nasopharyngeal carcinoma. Ann
Otol Rhinol Laryngol. 122:210–215. 2013.
|
|
32
|
Huang W, Yu LF, Zhong J, et al:
Angiotensin II type 1 receptor expression in human gastric cancer
and induces MMP2 and MMP9 expression in MKN-28 cells. Dig Dis Sci.
53:163–168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carl-McGrath S, Gräntzdörffer I, Lendeckel
U, Ebert MP and Röcken C: Angiotensin II-generating enzymes,
angiotensin-converting enzyme (ACE) and mast cell chymase (CMA1),
in gastric inflammation may be regulated by H. pylori and
associated cytokines. Pathology. 41:419–427. 2009. View Article : Google Scholar : PubMed/NCBI
|
